PlainPharmaWatch

CMS Open Payments · Program Year 2024

RedHill Biopharma Inc.

RedHill Biopharma Inc. reported $68,760.10 across General Payments, Research, and Ownership to 1,502 physicians and teaching hospitals across 1,507 transactions.

See the rankings → How this is sourced
$68.8K
All-tracks total
1,507
Transactions
1,502
Recipients
−$197.7K
General Payments vs PY2023

RedHill Biopharma Inc. reported $68,760.10 across all CMS Open Payments tracks (General + Research + Ownership) to 1,502 physicians and teaching hospitals in Program Year 2024 - ranking #1274 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $37,325.35, averaging $45.78 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer redhill-biopharma-inc RedHill Biopharma Inc.

$68.8K · #1274/1,925 · 0.0% industry · PY2024

  • TOT $68.8K
  • RANK #1274
  • SHARE 0.0%
  • TXN 1,507
  • RCP 1,502
  • CAT 1
  • GEN $37.3K
  • ΔGEN −$197.7K
  • TOP1 0.8%
  • PY 2024

Volume peers

Nearest volume peer: Nexus CMF, LLC ($69.0K)

Coastal Medical Technologies…$69.5KNexus CMF, LLC$69.0KRedHill Biopharma Inc. (this)$68.8KShimadzu Precision Instrumen…$67.9KImmunitybio, Inc.$67.8K
All-tracks payment totals near RedHill Biopharma Inc. (CMS Open Payments PY2024)

RedHill Biopharma Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

RedHill Biopharma Inc.'s CMS-reported General Payments decreased by $197.7K (−84.1%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: REDHILL BIOPHARMA INC.PY2023: REDHILL BIOPHARMA INC.PY2024: RedHill Biopharma Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$235.0KPY2024$37.3K
PY2023
$234,991.98
PY2024
$37,325.35

What the Data Shows for RedHill Biopharma Inc.

Rank #1274 of 1,925 companies in CMS Open Payments for 2024 belongs to RedHill Biopharma Inc., which reported $68,760.10 across 1,507 transactions to 1,502 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $45.63 per transaction and $45.78 per recipient.

Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $37.3K across 1,502 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

RedHill Biopharma Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $37.3K, 100.0% of General Payments.

How RedHill Biopharma Inc. divides its payments

How the reported total splits across payment categories

1. Food and Beverage$37.3K
Payment Type Amount Transactions
Food and Beverage $37.3K 1,502

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,131.71 (3.0%) of $37,325.35 in this company's General Payments records across 1,053 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for RedHill Biopharma Inc.

The five named recipients with the highest reported General Payments from this company

Bridget Marrin$294.89Ling Lee$235.90Eric Cheung$213.90Diane Nguyen Dr$199.18Hoa Nguyen Dr$187.84
  1. 1

    Bridget Marrin

    $294.89 across 2 reported transactions

  2. 2

    Ling Lee

    $235.90 across 6 reported transactions

  3. 3

    Eric Cheung

    $213.90 across 5 reported transactions

  4. 4

    Diane Nguyen Dr

    $199.18 across 4 reported transactions

  5. 5

    Hoa Nguyen Dr

    $187.84 across 3 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as RedHill Biopharma Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about RedHill Biopharma Inc..

Intuitive Surgical, Inc.

HHI 18

GlaxoSmithKline, LLC.

HHI 18

Kestra Medical Technology Services, Inc.

HHI 17

Regeneron Healthcare Solutions, Inc.

HHI 19

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with RedHill Biopharma Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download RedHill Biopharma Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.